PALISADE CAPITAL MANAGEMENT, LP - ARRAY BIOPHARMA INC ownership

Back to all holdings Add to watchlist

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 172 filers reported holding ARRAY BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q4 2016$97,000
-34.5%
11,000
-50.0%
0.00%
-20.0%
Q3 2016$148,000
+62.6%
22,000
+10.0%
0.01%
+66.7%
Q3 2015$91,000–20,000–0.00%–
 Download
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders